These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 12393174)

  • 1. An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II.
    Das S; Rruga F; Montepeloso A; Dimartino A; Spadini S; Corre G; Patel J; Cavalca E; Ferro F; Gatti A; Milazzo R; Galy A; Politi LS; Rizzardi GP; Vallanti G; Poletti V; Biffi A
    Mol Ther; 2024 Mar; 32(3):619-636. PubMed ID: 38310355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc.
    Manzoli R; Badenetti L; Bruzzone M; Macario MC; Rubin M; Dal Maschio M; Roveri A; Moro E
    Cell Death Dis; 2024 Apr; 15(4):269. PubMed ID: 38627369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment.
    D'Avanzo F; Rigon L; Zanetti A; Tomanin R
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain.
    Cardona C; Benincore E; Pimentel N; Reyes LH; Patarroyo C; Rodríguez-López A; Martin-Rufian M; Barrera LA; Alméciga-Díaz CJ
    Heliyon; 2019 May; 5(5):e01667. PubMed ID: 31193135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).
    Stapleton M; Kubaski F; Mason RW; Yabe H; Suzuki Y; Orii KE; Orii T; Tomatsu S
    Expert Opin Orphan Drugs; 2017; 5(4):295-307. PubMed ID: 29158997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris.
    Pimentel N; Rodríguez-Lopez A; Díaz S; Losada JC; Díaz-Rincón DJ; Cardona C; Espejo-Mojica ÁJ; Ramírez AM; Ruiz F; Landázuri P; Poutou-Piñales RA; Cordoba-Ruiz HA; Alméciga-Díaz CJ; Barrera-Avellaneda LA
    Biotechnol Appl Biochem; 2018 Sep; 65(5):655-664. PubMed ID: 29633336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer.
    Di Francesco C; Cracco C; Tomanin R; Picci L; Ventura L; Zacchello E; Di Natale P; Anson DS; Hopwood JJ; Graham FL; Scarpa M
    Gene Ther; 1997 May; 4(5):442-8. PubMed ID: 9274721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein.
    Lu JZ; Boado RJ; Hui EK; Zhou QH; Pardridge WM
    Biotechnol Bioeng; 2011 Aug; 108(8):1954-64. PubMed ID: 21351076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro.
    Daniele A; Tomanin R; Villani GR; Zacchello F; Scarpa M; Di Natale P
    Biochim Biophys Acta; 2002 Dec; 1588(3):203-9. PubMed ID: 12393174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.